FORWARD PHARMA A/S AND THE BANK OF NEW YORK MELLONDeposit Agreement • October 9th, 2014 • Forward Pharma a/S • Pharmaceutical preparations • New York
a Danish public limited liability company) [·] American Depositary Shares Representing an Aggregate of [·] Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • October 9th, 2014 • Forward Pharma a/S • Pharmaceutical preparations • New York
Forward Pharma A/S, a Danish public limited liability company (the “Company”), confirms its agreement with the several Underwriters named in Schedule A hereto (the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for whom Leerink Partners LLC (“Leerink”) and Jefferies LLC (“Jefferies”) are acting as representatives (in such capacity, the “Representatives”), with respect to (i) the sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of the respective numbers of the American Depositary Shares (the “ADSs”), each ADS representing one of the Company’s ordinary shares, nominal value DKK 0.10 per share (the “Ordinary Shares”), set forth in Schedule A hereto and (ii) the grant by the Company to the Underwriters, acting severally and not jointly, of the option described in Section 2(b) hereof to purchase all or any part of [·] additional ADSs solely for the purpose of covering over-al
STOCK LENDING AGREEMENT Between Nordic Biotech Opportunity Fund K/SStock Lending Agreement • October 9th, 2014 • Forward Pharma a/S • Pharmaceutical preparations
Exhibit 10: Form notice from the Company and the Lender to the Transfer Agent of the redelivery of the Option Lending Shares
